MSN.com: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
MSN.com: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
Share This Story
Newsroom health conditions id
192
yahoo! news: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
John Sarantopoulos, MD, associate professor, Department of Medicine, Division of Hematology and Oncology, and medical oncologist, Mays Cancer Center, was mentioned in this article. Read More
Share This Story
Associated Press: Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082
Associated Press: Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082
Share This Story
KENS 5: Healthy SA — Reducing both obesity and colon cancer risk with GLP-1s
KENS 5: Healthy SA — Reducing both obesity and colon cancer risk with GLP-1s
Share This Story
Robotic surgery on forefront of HPV-related cancer treatment
This story was first published in the February 2026 issue of the Bexar County Medical Society’s San Antonio Medicine magazine. New face of head and neck cancer A healthy 40-year-old man visits his primary care physician for a mass on his neck. He doesn’t smoke, has no risk factors for head and neck cancer, […]
Share This Story